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Transforming growth factor  (TGF-) regulates inflam-
mation, immunosuppression, and wound-healing cas-
cades, but it remains unclear whether any of these func-
tions involve regulation of myeloid cell function. The
present study demonstrates that selective deletion of
TGF-RII expression in myeloid phagocytes i) impairs
macrophage-mediated suppressor activity, ii) increases
baseline mRNA expression of proinflammatory chemo-
kines/cytokines in the lung, and iii) enhances type 2
immunity against the hookworm parasite Nippos-
trongylus brasiliensis. Strikingly, TGF-–responsive my-
eloid cells promote repair of hookworm-damaged lung
tissue, because LysMCreTGF-RIIflox/flox mice develop
emphysemamore rapidly thanwild-type littermate con-
trols. Emphysematous pathology in LysMCreTGF-
RIIflox/flox mice is characterized by excessive matrix
metalloprotease (MMP) activity, reduced lung elasticity,
increased total lung capacity, and dysregulated respira-
tion. Thus, TGF- effects on myeloid cells suppress hel-
minth immunity as a consequence of restoring lung
function after infection. (Am J Pathol 2012, 181:897–906;
http://dx.doi.org/10.1016/j.ajpath.2012.05.032)
Transforming growth factor  (TGF-) constitutes a su-
perfamily of molecules that regulate cellular proliferation,
differentiation, and survival of hematopoietic and nonhe-
matopoietic lineages.1,2 TGF-1, TGF-2, and TGF-3
mediate their biological effects through transforming
growth factor-beta receptor type II (TGF-RII), which fa-
cilitates Smad-dependent and Smad-independent gene
transcription.3 The immunosuppressive role for TGF- is
well established, in that mice lacking expression of TGF-
RII in all hematopoietic cells or specifically in T cellsdevelop lethal multiorgan inflammatory disease.4–7 This
cytokine also regulates tissue remodeling and fibrosis
through mechanisms that involve stromal cells and fibro-
blasts.8 Whether TGF-–dependent effects on myeloid
lineage cells serve important roles in immunosuppression
and mucosal repair remains entirely unclear.9–11
Given that TGF- suppresses T-lymphocyte effector
functions, this cytokine may promote the chronicity of
helminth infestations through suppressing TH2-domi-
nated immune responses.7,12–14 Indeed, some parasitic
helminths produce TGF-–like molecules in their excre-
tions, exemplifying the importance of this cytokine in
host-pathogen interactions.15 In addition, TGF- pro-
motes extracellular matrix deposition that may serve as a
mechanism to limit excess organ damage in worm-in-
fected hosts.16,17 For example, the murine hookworm
parasite Nippostrongylus brasiliensis causes severe hem-
orrhagic lung injury within days of infection.18 Worm
egress between 3 and 5 days after infection is followed
by progressive airway remodeling and fibrosis that re-
sembles certain pathophysiological features of murine
asthma.19 Moreover, N. brasiliensis-infected mice develop
an emphysematous-like pathology beyond 150 days after
infection, characterized by matrix metalloprotease (MMP)
production from alternatively activated macrophages
(AAM).20 Whether TGF- serves any role in host immu-
nity and/or tissue immunopathology after N. brasiliensis
infection has not been tested.
For the present study, mice deficient for TGF-RII ex-
pression in macrophages and neutrophils were gener-
ated (LysMCreTGF-RIIflox/flox) to test whether TGF-–de-
pendent effects on myeloid lineage cells regulated type 2
immunity and pulmonary repair after N. brasiliensis infec-
tion. Data presented here indicate that LysMCreTGF-
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proliferation and TH2-dominated inflammation, which was
associated with reduced worm egg production. The in-
fection-induced expression of AAM-associated genes
(Retnla, encoding RELM, and Arg1, encoding arginase I)
and extracellular matrix deposition (collagen and fi-
bronectin) were moderately affected in the absence of
TGF-–responsive myeloid cells. However, LysMCreTGF-
RIIflox/flox mice had marked defects in pulmonary tissue
repair characterized by dysregulated matrix metallopro-
tease activity and emphysematous pathology, which
demonstrates a previously unrecognized mechanism for
TGF- effects on myeloid cells in regulating immunity and
wound healing after hookworm infection.
Materials and Methods
Mice and Parasites
All experiments used sex- and age-matched mice on a
wild-type (WT) C57/BL6 background. TGF-RIIflox/flox
mice (strain number 01XN5) were obtained from the Na-
tional Cancer Institute mouse repository.21 LysMCre mice on
aWTC57/BL6 backgroundwere obtained from the Jackson
Laboratory (Bar Harbor, ME). These strains were inter-
crossed to generate LysMCreTGF-RIIflox/flox and TGF-
RIIflox/flox strains. N. brasiliensis was maintained in the lab-
oratory using established protocols. Naïve mice were
inoculated subcutaneously with 750 infectious third-stage
larvae (L3). Worm burdens were assessed by opening
mouse intestines longitudinally and incubating them in PBS
at 37°C for 3 hours in a modified Baermann apparatus, in
which tissues were placed in a sieve atop a 250-mL beaker.
Parasites that collected at the bottom were counted. For
fecal egg counts, feces were collected, weighed, and incu-
bated in saturated NaCl solution; eggs counted using
McMaster slides, as described previously.22 The Institu-
tional Animal Care and Use Committee at the Cincinnati
Children’s Hospital Medical Center approved all proce-
dures.
Lung Histopathology
To assess airway inflammation, lungs were excised and
fixed in 10% formalin, washed inmethanol, dehydrated, and
embedded in paraffin and cut into 5-m sections. Sections
were mounted on slides and stained with H&E or Masson’s
trichrome as prepared at the Cincinnati Children’s Hospital
Medical Center morphology core facility. The left lung was
removed and fixed in 10% neutral buffered formalin. Lungs
were bisected and oriented cut side down in a paraffin
block such that sections would reveal cross-sections of
consistent airways for comparison. A Nikon Eclipse E600
microscope fitted with a 40 objective lens (Nikon Plan
Apo) was used for image acquisition; photos were captured
with a SPOT Diagnostics RT slider digital color camera
using a SPOT Diagnostics imaging system (Sterling
Heights, MI). Hydroxyproline measurements were per-
formed as described previously.23ELISA and Real-Time PCR
RNA was treated with DNase I, and cDNA was prepared
using SuperScript II Reverse Transcriptase (Life Technolo-
gies-Invitrogen, Carlsbad, CA). Real-time PCR was per-
formed on a GeneAmp 7500 instrument (Life Technologies-
Applied Biosystems, Foster City CA) with SYBR Green
detection reagent. For the genes evaluated, CT values were
determined and expressed using the 1/CT method, as
described previously.12 Themousewound-healing RT2 Pro-
filer quantitative RT-PCR array was used to evaluate the
expression of genes relevant to the wound-healing re-
sponse, according to the manufacturer’s instructions
(SABiosciences, Frederick, MD). Pooled cDNA samples
from three individual mice were used for analysis.
Mouse cytokine enzyme-linked immunosorbent assay
(ELISA) kits specific for IL-13 and TGF- were obtained
from eBioscience (San Diego, CA). Total MMP activity
was determined by a commercially available fluorometric
assay (Enzo Life Sciences, Farmingdale, NY).
Flow Cytometric Analyses
Single-cell suspensions of lung tissue or bone marrow-
derived macrophage (BMDM)-T cell cocultures were
stained with one or more of the following fluorescently
labeled monoclonal antibodies (mAbs): anti-mouse TGF-
RII (R&D Systems), anti-mouse CD25 (clone 7D4), anti-
mouse CD68 (FA-11), anti-mouse CD11c (clone N418),
CD11b (clone M1/70), CD45 (clone 30-F11), and isotype
control (MOPC-173) (eBioscience). Intracellular bro-
modeoxyuridine (BrdU) staining was performed accord-
ing to the manufacturer’s instructions (BD Biosciences,
San Jose, CA). Acquisition was performed with a FAC-
SCalibur cell sorting system (BD Biosciences, San Jose,
CA), and data were analyzed with FlowJo software (v8.8;
Tree Star, Ashland, OR).
Isolation of Lung Tissue Cells and
Bronchoalveolar Lavage Fluid Collection
Lungs were perfused with 1 PBS and minced with scis-
sors, followed by digestion in serum-free RPMI 1640 me-
dium containing Liberase CI (0.5 mg/mL; Roche, Indianap-
olis, IN) and DNase I (0.5 mg/mL; Sigma-Aldrich, St. Louis,
MO) RPMI 1640 medium for 30 minutes at 37°C with shak-
ing. Samples were further disassociated by repeated pas-
sage through a 10-mL syringe fitted with an 18-gauge nee-
dle and finally passed through a 70-mm cell strainer to
obtain a single-cell suspension. For cytokine measure-
ments, bronchoalveolar lavage fluid (BALF) was collected
using established protocols followed by concentration with
Amicon Ultra centrifugal filter units with molecular weight
cutoff at 3000 daltons (Millipore, Billerica, MA).
In Vivo Cytokine Capture Assays
Relative amounts of in vivo IL-4, IFN-, and IL-10 secretion
were determined by an in vivo cytokine capture assay.24
Injected biotin-labeled anti-cytokine mAbs in this assay
form complexes with the secreted cytokines they specifi-
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cytokines. Consequently, the complexes accumulate in vivo
and can be measured by ELISA, using wells coated with
mAbs that bind to an epitope on the cytokine that is not
blocked by the injected mAb. Bound biotin-mAb/cytokine
complexes are detected with horseradish peroxidase-
streptavidin, followed by a luminogenic substrate.
OTII-BMDM Coculture
CD4 cells were isolated from naïve ovalbumin-specific T
cell receptor transgenic mice (OTII), as described previ-
ously.12 BMDMs were generated from 6-day culture su-
pernatant from a macrophage colony-stimulating factor
(M-CSF)-secreting cell line. BMDMs were either left un-
treated or exposed to recombinant human TGF- (endo-
toxin values of 0.1 ng/mL; PeproTech, Rocky Hill, NJ)
for 16 hours, then pulsed with 50 g/well endotoxin-free
chicken egg ovalbumin for 8 hours, washed several
times, and cocultured with purified naïve OT-II CD4
cells at a ratio of 10:1 (CD4/M) for 72 to 96 hours. At 16
hours before harvest, 10 mg/mL BrdU was added to
cultures.
Measurement of Airway Physiology
Unrestrained whole-body plethysmograph chambers
(Buxco Research Systems, Wilmington, NC) were used to
evaluate pulmonary airflow in the upper and lower respira-
tory tract. In this approach, chamber pressure measures
the difference between expansion of the thoracic cavity and
the volume of air removed from (or added to) the chamber
during inspiration (or expiration). Exposure of mice to in-
creasing doses of methacholine was used to determine the
enhanced pause response. Invasive measurements of air-
way responsiveness were made on a flexiVent apparatus
(Scientific Respiratory Equipment, Montreal, QC, Canada).
Mice were anesthetized with xylazine and sodium pento-
barbital. The mice were placed on a rectal thermometer-
controlled heating pad to maintain body temperature at
37°C. Mouse tracheas were cannulated with an 18-gauge
blunt needle, and the mice were ventilated at 150 breaths/
minute and 3.0 cm water positive end expiratory pressure.
Mice were paralyzed with 0.8 mg/kg pancuronium bromide
and allowed to stabilize on the ventilator for 2 minutes.
Two total lung capacity perturbations were then per-
formed for airway recruitment before baseline measure-
ment. Measurements were made using a 1.25-second,
2.5-Hz volume-driven oscillation applied to the airways by a
computer-controlled piston (snapshot perturbation). Newto-
nian resistance (RN), inertance (I), tissue damping (G), and
tissue elastance (H) were determined by fitting the data to a
constant phase model of airway mechanics. Tissue elastic-
ity was calculated from the constant-phase model, which
applies fixed-amplitude, wide-frequency (0.25 to 20 Hz)
waves to lungs and allows this model to differentiate be-
tween the mechanical properties of the airways and the
lung tissue. Total lung capacity was calculated from one
parameter of the Salazar-Knowles equation25 (fitting data
from PV-loops) that represents the total lung capacity on the
total volume axis.Statistical Analysis
Statistical significance was assessed by either two-tailed
Student’s t-test (two groups) or analysis of variance (anal-
ysis of variance) for multiple groups with a post hoc
Tukey’s test to determine significance. P  0.05 was
considered significant. All analyses were performed us-
ing Prism GraphPad 4.0 software (GraphPad Software,
La Jolla, CA).
Results
M-TGF-RIIKO Mice Delete TGF-RII on
Alveolar Macrophages and Have a Baseline
Increase of Lung Inflammation
Tissue-specific deletion of TGF- signaling components
in mice has greatly increased our understanding of he-
matopoietic and nonhematopoietic cell regulation.7,26,27
To investigate the role of TGF- in myeloid lineage cells,
C57BL/6 mice expressing a LoxP-flanked TGF-RII al-
lele21 were intercrossed with a mouse strain that ex-
presses Cre recombinase under control of the lysozyme
M promoter.24 Progeny with a LysMCreGF-RIIflox/flox
(hereafter referred to as M-TGF-RIIKO mice) genotype
were compared with their littermate LysMCre-negative
TGF-RIIflox/flox mice (hereafter referred to as WT mice)
throughout our studies.
TGF-RII deletion efficiency in myeloid cells was eval-
uated in cell suspensions of lung tissue from naïve WT
and M-TGF-RIIKO mice. Anti-mouse mAbs specific for
CD45, CD68, CD11c, and TGF-RII were used for eval-
uation via flow cytometry. FSChighSSClow gated cells that
coexpressed CD45 and CD68, revealed two distinct pop-
ulations that were either CD11chigh or CD11clow (Figure
1A). Although the CD11chigh population in M-TGF-
RIIKO mice expressed a threefold lower level of TGF-
RII than WT mice, there were no differences in TGF-RII
levels between strains in the CD11clow population (Figure
1, A and B). This indicated that alveolar macrophages
had TGF-RII expression, as these cells express high
levels of CD11c, compared with intermediate CD11c lev-
els on lung dendritic cells.28,29
Lung tissues of naïve M-TGF-RIIKO mice had a
relative greater number of FSClowSSChigh cells than WT
mice (Figure 1A), indicative of a baseline increase in gran-
ulocytic inflammation. To further evaluate naïve M-TGF-
RIIKO mice, a commercially available quantitative RT-
PCR-based cDNA array was used to assess inflammatory
and tissue repair genes (Figure 1C). Results showed that
M-TGF-RIIKO mice generated a more than twofold in-
creased expression of chemokine genes (Ccl12, Ccl7,
Cxcl1, Cxcl3, and Cxcl5), granulocyte colony stimulating
factor (Csf3), and cytokine genes (Il10 and Ifng), compared
with WT mice (Figure 1C). In contrast, M-TGF-RIIKO
mice showed a marked down-regulation of epidermal
growth factor (Egf), an epithelial cell growth and mucosal
repair gene (Figure 1C). Altogether, alveolar macrophages
and not dendritic cells in the lungs of M-TGF-RIIKO mice
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marked dysregulation of inflammatory/tissue repair genes.
Macrophages from M-TGF-RIIKO Mice Fail
to Suppress T-Cell Activation
TGF- inhibits leukocyte activation and proliferation
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Figure 1. Naïve M-TGF-RIIKO mice have reduced TGF-RII expression
on lung macrophages and develop pulmonary inflammation at baseline. A:
Flow cytometry gating strategy for the identification of TGF-RII expression
on CD11c-positive cell populations in whole lung digests of naïve wild-type
(WT) and M-TGF-RIIKO mice. FSChighSSClow cells (R1) that coexpressed
CD45 and CD68 (R2) were evaluated for surface expression of CD11c and
TGF-RII. In the contour plots, the percentage of positive cells is indicated in
each quadrant. B: Mean fluorescence intensity (MFI) for TGF-RII on the
CD11clow and CD11chigh populations. C: Results of a quantitative RT-PCR-
based wound-healing array performed on whole lung tissues from naïve WT
and M-TGF-RIIKO strains. Data are expressed as means  SEM (B) or
from pooled samples representative of two independent experiments (C).
**P  0.01. n  4 mice (A and B); n  2 or 3 mice (C) per group.through diverse mechanisms, one example of which isthrough promoting a suppressive phenotype in macro-
phages.30–32 To evaluate suppressor macrophage activ-
ity, BMDMs were generated from both mouse strains and
were used as the source of antigen presenting cells
(APC) in a coculture system with naïve antigen-specific
CD4 T cells.12 BMDMswere exposed tomedium only (mock
treatment), treated with rTGF- (10 ng/mL; TGF- treat-
ment), ovalbumin peptide 323–339 (1 mg/mL; OVA
treatment), or rTGF- and OVA-peptide (OVATGF-
treatment) for 16 hours, then were washed and cocultured
with CD4 T cells purified from ovalbumin-specific TCR
transgenic mice (OTII) at a 5:1 ratio (M:CD4 T cells) for
96 hours. Flow cytometry was used to evaluate the TCR-
CD4 cells (Figure 2A) for activation status and relative
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Figure 2. Bone marrow-derived macrophages (BMDMs) from M-TGF-
RIIKO mice lack TGF-–mediated suppression of antigen-specific T cell
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were administered medium only (Mock), 20 ng/mL recombinant murine
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and BrdU incorporation, respectively. Although the base-
line BrdU incorporation in the CD25-negative population
was moderately increased in M-TGF-RIIKO APC-T cell
cocultures, compared with the WT, this increase became
significant after the administration of OVA. Strikingly, an-
tigen-specific BrdU incorporation in cocultures of CD4 T
cells and OVA peptide-pulsed WT macrophages was
abrogated in the presence of TGF- treatment (1.9%),
whereas CD4 T cells in M-TGF-RIIKO APC-T cell
cocultures maintained a significant level of BrdU incor-
poration (17.6%), despite pre-exposure to TGF-–treated
macrophages (Figure 2B). These results suggest that
BMDMs from M-TGF-RIIKO mice displayed a marked
impairment of TGF-–mediated suppressor macrophage
function.
Mice That Lack TGF- Responsive Myeloid
Cells Generate Enhanced Type 2 Immune
Responses after N. brasiliensis Infection
Helminths can elicit TGF- production in their hosts as
part of an immune evasion strategy.33,34 To determine
whether TGF-–dependent effects on myeloid cells
serve an important role, WT and M-TGF-RIIKO mice
were subcutaneously infected with 500 N. brasiliensis
infective-stage larvae, and the numbers of parasite
eggs produced in the feces were monitored between 6
and 10 days after infection. Worm egg production ter-
minated more rapidly in M-TGF-RIIKO mice than in
WT mice at day 8 and 9 after infection (Figure 3A).
Adult worm numbers at day 9 after infection were mod-
erately reduced in M-TGF-RIIKO mice, compared
with WT mice (data not shown).
Next, type 2 cytokine and antibody production were
measured to determine whether TGF- effects on my-
eloid cells regulate the immune response to N. brasil-
iensis infection.22 Total serum levels of IgE were in-
creased in WT mice at 14 days after infection, but were
significantly higher in M-TGF-RIIKO mice (Figure
3B). The in vivo cytokine capture assay was used to
evaluate IL-4, IL-10, and IFN- levels in the sera of
naïve and infected WT and M-TGF-RIIKO mice. Mice
were injected with biotin-conjugated antibody on day
8, and then were bled on day 9 to determine the
amount of cytokine produced in the systemic circula-
tion. Congruent with N. brasiliensis infection-induced
IgE levels, the production of IL-4 was greater in M-
TGF-RIIKO mice, compared with the WT (Figure 3C).
In contrast, IFN- and IL-10 levels were low in both
strains and were not significantly different (Figure 3C).
Given that migratory N. brasiliensis larvae cause lung
injury and marked pulmonary type 2 inflammation,35
BALF was evaluated for cytokine production. Notably,
M-TGF-RIIKO mice produced greater amounts of
TGF- (Figure 3D) and IL-13 (Figure 3E) than WT litter-
mates at 9 days after infection. Taken together, these
data indicate that mice lacking TGF-–responsive my-
eloid cells develop more robust type 2 immunity than do
WT mice after N. brasiliensis infection.M-TGF-RIIKO Mice Develop Enhanced
Emphysematous Pathology after
N. brasiliensis Infection
N. brasiliensis L3 larvae cause severe hemorrhagic lung
injury within the first three days of primary inoculation.
Resolution of tissue damage occurs over months and is
marked by the accumulation of AAM, excess collagen
deposition, and progressive development of lung hyper-
responsiveness.20,36,37 We asked whether TGF- effects
on myeloid cells are important for the regulation of tissue
repair and pulmonary function. To this end, cohorts of WT
and M-TGF-RIIKO mice were evaluated longitudinally
by whole-body plethysmography after infection, to mon-
itor the progressive changes in breathing dynamics of
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902 Heitmann et al
AJP September 2012, Vol. 181, No. 3linergic stimulation, the infected M-TGF-RIIKO mice
developed a progressive increase in respiration time in
the weeks after parasite clearance, compared with their
WT cohorts (Figure 4A). Using this approach, respiration
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65% of total lung volume. Comparison of the methacholine-
induced enhanced pause (Penh) response between strains
revealed that WT mice developed a progressive and signif-
icant increase in Penh, whereas Penh values in M-TGF-
RIIKO mice did not increase over time (Figure 4B).
Compared with the WT, M-TGF-RIIKO mice pro-
duced higher levels of the profibrotic cytokines IL-13 and
TGF- in BALF at 9 days after infection. We therefore
subjected paraffin-embedded sections of lung tissue to
Masson’s trichrome stain, to evaluate whether there were
differences in collagen accumulation between strains.
Although there were no obvious differences in lung ar-
chitecture between naïve mice of either strain (Figure 4, C
and D), by 28 days after infection both strains showed
some evidence of moderate collagen accumulation, in-
dicative of subepithelial cell fibrosis (Figure 4, E and F).
Notably, the alveolar structure in M-TGF-RIIKO mice
was markedly defective, with large areas of irregular
bronchiolar dilation that resembled emphysematous bul-
lae and perivascular edema (Figure 4F). In contrast, WT
mice had moderate alveolar emphysema, with mildly
thickened lung interstitium and infiltrates of small lympho-
cytes and histiocytes.
In addition, a flexiVent apparatus was used to measure
airway mechanics in the two strains. Interestingly, there
were no differences between strains in methacholine-
induced airway resistance; however, infected M-TGF-
RIIKO mice had significantly reduced lung elasticity
(Figure 4G) and significantly greater total lung capacity
(Figure 4H), compared with WT mice at 28 days after
infection. M-TGF-RIIKO mice had more emphysema-
tous bullae, compared with WT mice at 28 days after
infection, as determined by our clinical scoring system
(Figure 4I). Taken together, these data show that hook-
worm infection-induced lung injury in M-TGF-RIIKO
mice results in more rapid emphysematous lung pathol-
ogy than in WT mice.20
TGF- Responsiveness in Myeloid Cells Is Not
Required for Alternative Macrophage Activation
or Infection-Induced Lung Fibrosis
Given the progressive accumulation of AAM and lung
fibrosis during the chronic repair phase of N. brasiliensis
infection,36 we evaluated whether TGF-–responsive my-
eloid cells were responsible for AAM gene expression
or profibrotic cytokines release during the chronic stages
of repair. Surprisingly, there were no differences between
strains in lung hydroxyproline content at 28 days after
infection (Figure 5A), but fibronectin levels were signifi-
cantly higher in M-TGF-RIIKO mice, compared with
WT mice (Figure 5B). BALF levels of TGF- and IL-13 at
day 28 after infection did not differ between strains (Fig-
ure 5, C and D).
Whole lung tissue was analyzed for the expression of
Arg1 and Retnla genes, which are strongly associated
with AAM and the wound-healing response.38 There
were no differences in Retnla expression, but significantly
increased Arg1 expression was noted in the lungs of
TGF- Regulates Lung Injury 903
AJP September 2012, Vol. 181, No. 3M-TGF-RIIKO mice, compared with WT mice at day 28
after infection (Figure 5, E and F). Taken together, these
data suggest that TGF-–dependent effects on myeloid
cells are not critical for hookworm-induced lung fibrosis,
profibrotic cytokine production, or the expression of
genes associated with AAM.
N. Brasiliensis-Induced Lung Injury in M-TGF-
RIIKO Mice Results in a Marked Dysregulation
of Matrix Metalloprotease Activity
M-TGF-RIIKO mice exhibited a marked dysregulation
of lung physiology after hookworm infection.39–41 We
therefore evaluated a wide array of inflammation and
wound-healing genes, again using the quantitative RT-
PCR-based cDNA array, to determine whether TGF-
effects on myeloid cells regulate chronic lung repair more
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Figure 5. M-TGF-RIIKO mice up-regulate fibronectin production and
arginase I expression during the chronic repair phase of hookworm-medi-
ated lung injury. WT and M-TGF-RIIKO mice were subcutaneously in-
fected with 750 N. brasiliensis infective-stage larvae (L3). Whole lung tissues
of naïve and infected mice at 28 days after infection were evaluated for
hydroxyproline levels of collagen in individual lobes of lung tissue (A), for
BALF levels of fibronectin (B), IL-13 (C), and TGF-1 (D), and for mRNA
expression levels of RELM (E) and arginase I (F). Data are representative of
three independent experiments. Data are expressed as means  SEM. *P 
0.05. n  6 to 8 mice per group.broadly. Comparison between strains at 28 days afterinfection revealed multiple genes that were either up- or
down-regulated more than twofold, compared with WT
controls (Figure 6A). Similar to differences between
strains before infection, M-TGF-RIIKO mice expressed
higher levels of proinflammatory chemokines and chemo-
kines genes (Ccl12, Ccl7, Csf3, Cxcl1, Cxcl3, Cxcl5, and
Tnf), compared with WT mice, but also the canonical
anti-inflammatory cytokine gene Il10.
There was evidence for broad dysregulation of MMP
activity, shown by increased expression of tissue inhibitor
of matrix metalloprotease 1 (Timp1), and increased ex-
pression of several matrix metalloprotease genes (includ-
ing Mmp1a and Mmp2) in M-TGF-RIIKO mice, com-
pared with WT mice (Figure 6A). Conversely, M-TGF-
RIIKO mice had a notable decrease in expression of
Egfr and Mmp7 (Figure 6A). Although N. brasiliensis-dam-
aged lung tissue has been demonstrated to express el-
evated Mmp12 levels, this gene was not part of the array
and could not be assessed.
Given the transcriptional dysregulation of several MMP
genes and Timp1, the overall MMP enzymatic activity in
BALF was determined. The M-TGF-RIIKO mice had
moderately increased baseline activity, but a significantly
greater infection-induced MMP activity, than WT mice at
day 28 (Figure 6B). Thus, TGF-–dependent regulation
of myeloid cell function serves a critical in vivo role for
suppression of cytokine/chemokine production and MMP
activity in lung tissues after N. brasiliensis infection.
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The present study demonstrated that TGF-–dependent
effects on myeloid lineage cells regulate type 2 re-
sponses and pulmonary repair mechanisms during N.
brasiliensis infection. Given that infected M-TGF-RIIKO
mice produced greater amounts of type 2 cytokines (IL-4
and IL-13) and greater emphysematous pathology than
WT mice, our data suggest that TGF- negatively regu-
lates host protection against hookworms, but critically
regulates infection-induced tissue damage. Indeed,
TGF- instructed myeloid cells to restrict the tissue levels
of inflammatory cytokine/chemokines and MMPs in the
lung, which demonstrates a previously unrecognized
mechanism for TGF-–responsive myeloid cells in the
host-protective mechanisms engaged in worm-infected
hosts.
Many pathogens elicit host-derived TGF- production,
but evidence that parasitic worms encode TGF-–like
molecules emphasizes the importance of this cytokine in
the context of helminth infection.15 Demonstration that
mice lacking TGF-–responsive myeloid cells develop
enhanced immunity and excessive immunopathology in
response to N. brasiliensis infection supports the notion
that TGF- promotes chronic worm infestations. Indeed,
TGF- neutralization results in the rapid development of
host immunity and worm clearance in otherwise chroni-
cally infected hosts.42 TGF- production during helminth
infections can suppress inflammation in distinct organ
environments.43 In addition to its role in lymphocyte reg-
ulation, we demonstrate an important role for TGF- spe-
cifically in myeloid cell function. Indeed, BMDMs ex-
posed to TGF- suppressed antigen-specific T-cell
proliferation, whereas those derived from M-TGF-
RIIKO mice failed to do so in our in vitro coculture sys-
tem. CD4 T cells isolated from N. brasiliensis-infected
M-TGF-RIIKO mice also showed greater degree of
BrdU incorporation and CD25 expression, compared
with similarly infected WT mice (data not shown). Al-
though our data show an important role for this mecha-
nism in the context of hookworm infection, it is likely that
TGF- responsiveness in myeloid cells promotes chronic
infections with other helminths.
M-TGF-RIIKO mice generated increased levels of
IgE and type 2 cytokines after N. brasiliensis infection,
compared with WT controls. It is likely that increased type
2 responses were responsible for the enhanced immu-
nity. Although this has not been formally demonstrated,
the underlying mechanism for accelerated type 2 immu-
nity could be enhanced production of macrophage-de-
rived IL-33, because we have demonstrated that TGF- is
a negative regulator of IL-33 production in tissue macro-
phages.44 Indeed, IL-33 is a strong inducer of type 2
inflammation and drives the expulsion of the gastrointes-
tinal helminth Trichuris muris.45,46 IL-33 may also drive the
differentiation of AAM,47 which promotes immunity
against parasitic helminths. Although it remains unclear
whether macrophage-derived IL-33 was indeed respon-
sible for the enhanced immunity against N. brasiliensis,
our data show that TGF- effects on myeloid cells antag-
onizes the expression of arginase I, a central effectormolecule expressed by AAM. Given the broad implica-
tion of AAM as key players in mucosal immunity, it will
be important to evaluate whether M-TGF-RIIKO mice
have altered susceptibility to other types of patho-
gens.12,38
Curiously, naïve M-TGF-RIIKOmice demonstrated a
moderate increase of lung inflammation, as shown by
increased numbers of SSChigh cells (characteristic of
granulocytes). Given that TGF- suppresses neutrophil
effector function,48 we cannot rule out the possibility that
lack of neutrophil responsiveness to TGF- in the M-
TGF-RIIKO strain partially explains this phenotype.
Nonetheless, the increased baseline inflammation was
associated with increased expression of myeloid-specific
chemokine genes such as Ccl12, Ccl7, Cxcl1, Cxcl3, and
Cxcl5,49,50 as well as a marked reduction in wound-heal-
ing genes such as Egf, which regulates mucosal barrier
integrity. Furthermore, our observation that M-TGF-
RIIKO mice had dysregulated MMP gene expression at
baseline and after N. brasiliensis infection is consistent
with the established role for TGF- in the negative regu-
lation of MMPs from a variety of cellular sources.10,51
Importantly, TGF- responsiveness in myeloid cell
function helps to maintain pulmonary function after N.
brasiliensis infection-induced lung injury. Loss of this
pathway in M-TGF-RIIKO mice resulted in phenotypi-
cal characteristics of chronic obstructive pulmonary dis-
ease (COPD)/emphysema, including loss of tissue elas-
ticity, increased total lung capacity, and destruction of
alveolar structure.52,53 Twomethods were used to evaluate
lung mechanics as surrogate markers for the quality of
pulmonary repair in the weeks after parasite expulsion. First,
we used the Buxco system, which has been widely used for
evaluation of the airflow changes that characterize allergic
asthma, including smooth muscle hypercontractility, mucus
accumulation, and inflammatory cell recruitment. However,
it has become increasingly appreciated that this method of
evaluating lung function in mice does not accurately re-
flect airway hyper-responsiveness normally associated
with allergic asthma, because noninvasive plethysmog-
raphy records only the overall changes in air pressure
during the breathing cycle.54 This does not allow Penh
(enhanced pause) to distinguish between airflow ob-
struction of the upper or lower airway.54 Thus, our data
showing that the infection-induced progression of Penh
values in M-TGF-RIIKO mice were markedly less than
those in WT mice reflects only the larger areas of lung
tissue that remained unrepaired in the former, compared
with the latter. Thus, methacholine-induced bronchocon-
striction is markedly less pronounced in M-TGF-RIIKO
mice because of an overall increase in total lung capac-
ity. Indeed, the respiration time RT was significantly lon-
ger in M-TGF-RIIKO mice than in WT mice.
We also used a flexiVent system, which requires intra-
tracheal intubation to specifically interrogate lung me-
chanics in the lower airway. Using this method, we found
no difference between strains in methacholine-induced
airway resistance (data not shown), but a significant re-
duction of lung tissue elasticity and increase in total lung
capacity in M-TGF-RIIKO mice, compared with WT
littermates. Thus, our data are consistent with a more
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worm-infected mice that lack TGF-–responsive myeloid
cells. The central pathological feature of emphysema is
the collapse of alveolar septae, which results in abnor-
mally large airspaces.55–57 These large cavities that re-
sult from septal rupture are termed bullae, a pathological
feature that was readily apparent in the lung tissues of
M-TGF-RIIKO mice by 21 to 28 days after infection.
The current consensus is that COPD/emphysema is pre-
cipitated by excess production of proteolytic enzymes,
such as neutrophil elastase or MMPs.53 Moreover, hu-
mans with genetic defects in protease neutralizing en-
zymes, such as 1-anti-trypsin deficiency, show an in-
creased risk for the development of emphysema.58
Importantly, defects in TGF-RII signaling have been im-
plicated in emphysema/COPD pathogenesis.59,60 TGF-
may directly regulate MMP activity through inducing
TIMP genes.51,61 There was an overall increase of total
MMP activity in BALF of M-TGF-RIIKO mice at 28 days
after infection, compared with WT mice. This is consistent
with increased expression of MMP12 from alveolar mac-
rophages after N. brasiliensis infection. However, MMP12-
deficient mice are not protected from hookworm-induced
emphysema.20 Thus, it remains unclear how TGF- ef-
fects on myeloid cells regulate the progression of emphy-
sema. In conclusion, we have demonstrated that the in
vivo effects of TGF- on myeloid phagocytes suppress
host immunity during parasitic worm infection and limit
the excessive tissue injury that culminates in chronic lung
disease.
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